A detailed history of Ubs Oconnor LLC transactions in Insulet Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 4,021 shares of PODD stock, worth $1.06 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,021
Holding current value
$1.06 Million
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$180.69 - $239.01 $67,578 - $89,389
374 Added 10.26%
4,021 $935,000
Q2 2024

Aug 14, 2024

SELL
$161.02 - $206.98 $837,304 - $1.08 Million
-5,200 Reduced 58.78%
3,647 $735,000
Q1 2024

May 15, 2024

SELL
$163.6 - $209.11 $32,720 - $41,822
-200 Reduced 2.21%
8,847 $1.52 Million
Q4 2023

Feb 14, 2024

SELL
$127.77 - $221.42 $683,952 - $1.19 Million
-5,353 Reduced 37.17%
9,047 $1.96 Million
Q3 2023

Nov 14, 2023

BUY
$154.67 - $290.89 $2.23 Million - $4.19 Million
14,400 New
14,400 $2.3 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.